• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.鲍曼不动杆菌对头孢菌素和青霉素的异质性耐药。
J Clin Microbiol. 2012 Mar;50(3):721-6. doi: 10.1128/JCM.05085-11. Epub 2011 Dec 21.
2
[Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].[从临床样本中分离的鲍曼不动杆菌菌株中β-内酰胺酶相关耐药性的分子特征分析]
Mikrobiyol Bul. 2014 Jul;48(3):365-76.
3
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.β-内酰胺酶抑制剂克拉维酸、舒巴坦和他唑巴坦单独或与β-内酰胺类联合应用对经流行病学特征分析的多重耐药鲍曼不动杆菌菌株的体外活性。
Antimicrob Agents Chemother. 2004 May;48(5):1586-92. doi: 10.1128/AAC.48.5.1586-1592.2004.
4
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.对碳青霉烯类敏感鲍曼不动杆菌的异质性耐美罗培南。
J Clin Microbiol. 2009 Dec;47(12):4055-9. doi: 10.1128/JCM.00959-09. Epub 2009 Oct 14.
5
Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.中国东部多药耐药鲍曼不动杆菌中整合子的流行情况及特征:一项多医院研究
Int J Environ Res Public Health. 2015 Aug 21;12(8):10093-105. doi: 10.3390/ijerph120810093.
6
Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.连续分离自噬血细胞性淋巴组织细胞增多症死亡患者的鲍曼不动杆菌的特征。
Int J Antimicrob Agents. 2017 Jan;49(1):102-106. doi: 10.1016/j.ijantimicag.2016.09.024. Epub 2016 Nov 8.
7
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].[多黏菌素/舒巴坦联合用药对耐碳青霉烯类鲍曼不动杆菌菌株的疗效评估]
Mikrobiyol Bul. 2016 Jul;50(3):460-5. doi: 10.5578/mb.26289.
8
Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.评估鲍曼不动杆菌中黏菌素异质性耐药的方法
Methods Mol Biol. 2019;1946:39-50. doi: 10.1007/978-1-4939-9118-1_4.
9
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.中国一家医院中耐碳青霉烯类鲍曼不动杆菌复合体的分型与特征分析
J Med Microbiol. 2004 Jul;53(Pt 7):653-656. doi: 10.1099/jmm.0.05513-0.
10
Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications.亚胺培南诱导多重耐药鲍曼不动杆菌产生异质性耐药的机制及临床意义。
Int J Antimicrob Agents. 2011 Apr;37(4):302-8. doi: 10.1016/j.ijantimicag.2010.12.015. Epub 2011 Feb 25.

引用本文的文献

1
Bacterial strain type and TEM-1 enzyme allele impact antibiotic susceptibility distribution in monoclonal populations: a single-cell droplet approach.细菌菌株类型和TEM-1酶等位基因对单克隆群体中抗生素敏感性分布的影响:一种单细胞液滴方法。
R Soc Open Sci. 2025 Jul 30;12(7):242143. doi: 10.1098/rsos.242143. eCollection 2025 Jul.
2
Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in complex.复杂情况下黏菌素异质性耐药的临床特征、分子流行病学及机制
Front Cell Infect Microbiol. 2025 Mar 6;15:1536058. doi: 10.3389/fcimb.2025.1536058. eCollection 2025.
3
Essential Oil to Enhance the Effect of Imipenem against Axenic and Co-Cultures of and .精油增强亚胺培南对[具体菌种]无菌培养物和共培养物的效果。 (注:原文中“and.”部分内容缺失,无法准确完整翻译)
Antibiotics (Basel). 2024 May 14;13(5):444. doi: 10.3390/antibiotics13050444.
4
Cephalosporin resistance, tolerance, and approaches to improve their activities.头孢菌素耐药性、耐受性及提高其活性的方法。
J Antibiot (Tokyo). 2024 Mar;77(3):135-146. doi: 10.1038/s41429-023-00687-y. Epub 2023 Dec 19.
5
Antimicrobial resistance patterns of and isolated from dogs presented at a veterinary academic hospital in South Africa.从南非一家兽医学术医院收治的犬只中分离出的[具体内容缺失]的抗菌药物耐药模式。
Vet World. 2023 Sep;16(9):1880-1888. doi: 10.14202/vetworld.2023.1880-1888. Epub 2023 Sep 17.
6
Performance of Fully Automated Antimicrobial Disk Diffusion Susceptibility Testing Using Copan WASP Colibri Coupled to the Radian In-Line Carousel and Expert System.使用 Copan WASP Colibri 与 Radian 在线转筒式自动分拣器和专家系统进行全自动抗菌药敏扩散试验的性能评估。
J Clin Microbiol. 2021 Aug 18;59(9):e0077721. doi: 10.1128/JCM.00777-21.
7
Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of .……的抗生素耐药谱、分子机制及创新治疗策略
Microorganisms. 2020 Jun 21;8(6):935. doi: 10.3390/microorganisms8060935.
8
Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.解析中国温州鲍曼不动杆菌临床分离株中的多黏菌素异质性耐药。
J Antibiot (Tokyo). 2020 Jul;73(7):463-470. doi: 10.1038/s41429-020-0289-2. Epub 2020 Mar 9.
9
Mechanisms and clinical relevance of bacterial heteroresistance.细菌异质性耐药的机制及临床意义。
Nat Rev Microbiol. 2019 Aug;17(8):479-496. doi: 10.1038/s41579-019-0218-1. Epub 2019 Jun 24.
10
Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings.检测和表征阴沟肠杆菌中的替加环素异质性耐药:临床和微生物学发现。
Emerg Microbes Infect. 2019;8(1):564-574. doi: 10.1080/22221751.2019.1601031.

本文引用的文献

1
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.产碳青霉烯酶肺炎克雷伯菌中的黏菌素异质性耐药
J Antimicrob Chemother. 2011 Apr;66(4):946-7. doi: 10.1093/jac/dkr007. Epub 2011 Jan 25.
2
Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.产 VIM-1 肺炎克雷伯菌同克隆株碳青霉烯类药物异质性耐药:对常规药敏试验的影响。
J Clin Microbiol. 2010 Nov;48(11):4089-93. doi: 10.1128/JCM.01130-10. Epub 2010 Sep 15.
3
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.RpoB 突变赋予金黄色葡萄球菌对达托霉素和万古霉素的双重异质性耐药性。
Antimicrob Agents Chemother. 2010 Dec;54(12):5222-33. doi: 10.1128/AAC.00437-10. Epub 2010 Sep 13.
4
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.1999 年至 2007 年台湾一家大学医院产厄他培南不敏感大肠埃希菌的流行率和特征。
Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1417-25. doi: 10.1007/s10096-010-1020-1. Epub 2010 Aug 11.
5
Multiresistant Acinetobacter baumannii infections: epidemiology and management.多重耐药鲍曼不动杆菌感染:流行病学与管理。
Curr Opin Infect Dis. 2010 Aug;23(4):332-9. doi: 10.1097/QCO.0b013e32833ae38b.
6
Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.产碳青霉烯酶肺炎克雷伯菌(KPC)临床分离株中美罗培南异质性耐药的特征。
J Clin Microbiol. 2010 Jul;48(7):2601-4. doi: 10.1128/JCM.02134-09. Epub 2010 May 26.
7
Treatment of Acinetobacter infections.治疗不动杆菌感染。
Clin Infect Dis. 2010 Jul 1;51(1):79-84. doi: 10.1086/653120.
8
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.多重耐药鲍曼不动杆菌:毒力和耐药机制。
Int J Antimicrob Agents. 2010 Mar;35(3):219-26. doi: 10.1016/j.ijantimicag.2009.10.024. Epub 2010 Jan 4.
9
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.对碳青霉烯类敏感鲍曼不动杆菌的异质性耐美罗培南。
J Clin Microbiol. 2009 Dec;47(12):4055-9. doi: 10.1128/JCM.00959-09. Epub 2009 Oct 14.
10
Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.由泌尿系统感染分离出的哌拉西林/他唑巴坦异质性耐药铜绿假单胞菌,用哌拉西林/他唑巴坦成功治疗。
J Antimicrob Chemother. 2008 Mar;61(3):757-8. doi: 10.1093/jac/dkm528. Epub 2008 Jan 15.

鲍曼不动杆菌对头孢菌素和青霉素的异质性耐药。

Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.

机构信息

Department of Medical Laboratory Science and Biotechnologya and Research Center for Medical Laboratory Biotechnology, Taiwan.

出版信息

J Clin Microbiol. 2012 Mar;50(3):721-6. doi: 10.1128/JCM.05085-11. Epub 2011 Dec 21.

DOI:10.1128/JCM.05085-11
PMID:22189112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3295183/
Abstract

Heteroresistance to antimicrobial agents may affect susceptibility test results and therapeutic success. In this study, we investigated heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii, a major pathogen causing nosocomial infections. Two A. baumannii isolates exhibited heteroresistance to ampicillin-sulbactam, ticarcillin-clavulanic acid, cefepime, and cefpirome, showing a distinct colony morphology of circular rings within the inhibition halos. Pulsed-field gel electrophoresis (PFGE) and outer membrane protein (OMP) analysis demonstrated that subpopulations around the disks/Etest strips and the original strains all belonged to the same PFGE type and OMP profile. Population analysis profile (PAP) showed the presence of heteroresistant subpopulations with high cefepime resistance levels in two isolates (008 and 328). Interestingly, A. baumannii 008 contained two peaks: one was grown in the presence of up to 1 μg of cefepime/ml, the other apparently occurred when the concentration of cefepime was raised to 256 μg/ml. After serial passages without exposure to cefepime, the PAP curve maintained the same trend observed for the original strain of A. baumannii 008. However, the PAP curve showed a shift to relatively lower cefepime resistance (from 256 to 64 μg/ml) in A. baumannii 328 after 10 passages in antibiotic-free Mueller-Hinton agar plates. Convergence to a monotypic resistance phenotype did not occur. Growth rate analysis revealed that slower growth in resistant subpopulations may provide a strategy against antibiotic challenge. To our knowledge, this is the first report of heteroresistance to cephalosporins and penicillins in A. baumannii.

摘要

抗微生物药物的异质性耐药可能影响药敏试验结果和治疗成功。在这项研究中,我们研究了鲍曼不动杆菌对头孢菌素和青霉素的异质性耐药性,鲍曼不动杆菌是引起医院感染的主要病原体。两株鲍曼不动杆菌对氨苄西林-舒巴坦、替卡西林-克拉维酸、头孢吡肟和头孢匹罗表现出异质性耐药性,在抑菌环内显示出明显的圆形环菌落形态。脉冲场凝胶电泳(PFGE)和外膜蛋白(OMP)分析表明,围绕纸片/ Etest 条的亚群和原始菌株都属于相同的 PFGE 型和 OMP 图谱。种群分析谱(PAP)显示,两株菌(008 和 328)中存在具有高头孢吡肟耐药水平的异质性耐药亚群。有趣的是,鲍曼不动杆菌 008 含有两个峰:一个在存在高达 1μg/ml 的头孢吡肟的情况下生长,另一个显然是在头孢吡肟浓度升高至 256μg/ml 时出现的。在没有暴露于头孢吡肟的情况下连续传代后,PAP 曲线保持与原始鲍曼不动杆菌 008 菌株相同的趋势。然而,在抗生素自由 Mueller-Hinton 琼脂平板中传代 10 次后,鲍曼不动杆菌 328 的 PAP 曲线显示出相对较低的头孢吡肟耐药性(从 256μg/ml 到 64μg/ml)的转变。没有出现向单一耐药表型的收敛。生长速率分析表明,耐药亚群的生长速度较慢可能是对抗生素挑战的一种策略。据我们所知,这是鲍曼不动杆菌对头孢菌素和青霉素异质性耐药的首次报道。